Stocktoria

PharmaCyte Biotech, Inc. PMCB

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2003-09-11

PharmaCyte Biotech, Inc. institutional holders

InvestorSharesValue% of company
CITADEL ADVISORS LLC369,481$284,5003.44%
RENAISSANCE TECHNOLOGIES LLC37,987$29,2500.35%
BlackRock Finance, Inc.13,346$26,1580.12%

% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.

Computed from company filings · US · as of 2025-04-30. Facts plus Stocktoria's own computed scores — not investment advice.